Researchers published the study covered in this summary on medRxiv.org as a preprint that has not yet been peer reviewed. Cardiovascular disease is the most common cause of death in people with type 2 ...
Furthermore, ischemia may not necessarily be localized to an entire myocardial area as in patients with epicardial coronary stenosis. Indeed myocardial ischemia may be patchily distributed in small ...
Bracco, the market leader in diagnostic imaging and the pioneer in cardiac positron emission tomography (PET) for more than ...
Researchers from the Mayo Clinic have reported findings from the preclinical evaluation of a novel cardiac targeting peptide (CTP)-based radiotracer – [68Ga]NOTA-CTP – being developed as a myocardial ...
The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...
A novel tracer for positron emission tomography (PET) myocardial perfusion imaging, called flurpiridaz F-18, performed well in a second phase III trial when it came to the detection of CAD in patients ...
Based on the clinical and scientific evidence now available, there are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded.” — Timothy Bateman, ...
A nuclear stress test shows how well blood travels through your heart at rest and exertion. Doctors often use it to check for coronary artery disease (CAD). Research suggests nuclear stress testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results